Mulmit

REGENXBIO Inc.REGENXBIO Inc.

RGNX Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-31170,441,000-161,198,000-193,878,000-3.76
2024-12-3183,328,000-233,346,000-227,102,000-4.59
2023-12-3190,242,000-268,128,000-263,494,000-6.02
2022-12-31112,724,000-262,876,000-280,321,000-6.5
2021-12-31470,347,000159,980,000127,840,0002.91

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-09-01Malzahn CraigChief Technology Officer234
2026-09-01Chan MitchellChief Financial Officer4,902
2026-08-27Ciongoli Gregory Austin53,407
2026-08-26Ciongoli Gregory Austin49,196
2026-08-25Ciongoli Gregory Austin15,432
2026-08-25Ciongoli Gregory Austin69,609
2026-08-01PAKOLA STEVEChief Medical Officer7,468
2026-08-01Christmas Patrick J.Chief Strategy & Legal Officer4,699
2026-07-02PAKOLA STEVEChief Medical Officer2,161
2026-07-02PAKOLA STEVEChief Medical Officer2,161
2026-07-02PAKOLA STEVEChief Medical Officer2,161
2026-07-01Simpson CurranChief Executive Officer6,818

8-K events

FiledItems
2026-08-25Officer or director change · Financial statements and exhibits
2026-08-24Regulation FD disclosure · Other events · Financial statements and exhibits
2026-08-06Results of operations · Financial statements and exhibits
2026-07-20Other events · Financial statements and exhibits
2026-06-29Other events · Financial statements and exhibits
2026-06-03Submission of matters to a vote · Other events
2026-05-14Results of operations · Regulation FD disclosure · Other events · Financial statements and exhibits
2026-03-20Entry into a material agreement
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Biological Products, (No Diagnostic Substances) — 같은 업종, 그리고 규모가 비슷한 기업Biological Products, (No Diagnostic Substances) — and other companies of a similar size

SEC가 같은 업종(Biological Products, (No Diagnostic Substances))으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Biological Products, (No Diagnostic Substances)) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.